Coherus BioSciences, Inc. (CHRS)
USD 0.8
(2.35%)
USD 0.8
(2.35%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 301.45 Million USD | -27.69% |
| 2022 | 397.83 Million USD | -25.33% |
| 2021 | 532.81 Million USD | 89.05% |
| 2020 | 281.83 Million USD | 21.89% |
| 2019 | 231.22 Million USD | 13.11% |
| 2018 | 204.41 Million USD | -12.53% |
| 2017 | 233.69 Million USD | -23.64% |
| 2016 | 306.03 Million USD | 22.85% |
| 2015 | 249.1 Million USD | 160.06% |
| 2014 | 95.78 Million USD | 147.23% |
| 2013 | 38.74 Million USD | -4.14% |
| 2012 | 40.41 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 76.69 Million USD | 3.29% |
| 2024 Q2 | 55.93 Million USD | -27.07% |
| 2023 Q4 | 74.25 Million USD | 0.52% |
| 2023 FY | 287.66 Million USD | -27.69% |
| 2023 Q1 | 83.3 Million USD | 0.8% |
| 2023 Q2 | 68.41 Million USD | -17.88% |
| 2023 Q3 | 73.87 Million USD | 7.98% |
| 2022 Q4 | 82.64 Million USD | -8.82% |
| 2022 Q3 | 90.63 Million USD | -2.42% |
| 2022 Q1 | 131.67 Million USD | 30.61% |
| 2022 Q2 | 92.88 Million USD | -29.45% |
| 2022 FY | 397.83 Million USD | -25.33% |
| 2021 Q2 | 95.11 Million USD | -60.84% |
| 2021 Q3 | 94.01 Million USD | -1.16% |
| 2021 FY | 532.81 Million USD | 89.05% |
| 2021 Q4 | 100.81 Million USD | 7.24% |
| 2021 Q1 | 242.88 Million USD | 195.04% |
| 2020 Q3 | 70.83 Million USD | 17.62% |
| 2020 Q4 | 82.32 Million USD | 16.22% |
| 2020 FY | 281.83 Million USD | 21.89% |
| 2020 Q1 | 68.45 Million USD | -3.61% |
| 2020 Q2 | 60.22 Million USD | -12.03% |
| 2019 Q4 | 71.01 Million USD | 33.0% |
| 2019 FY | 231.22 Million USD | 13.11% |
| 2019 Q3 | 53.39 Million USD | -3.51% |
| 2019 Q2 | 55.33 Million USD | 7.51% |
| 2019 Q1 | 51.47 Million USD | -14.93% |
| 2018 Q2 | 44.91 Million USD | 6.85% |
| 2018 Q1 | 42.03 Million USD | -9.54% |
| 2018 FY | 204.41 Million USD | -12.53% |
| 2018 Q4 | 60.5 Million USD | 6.2% |
| 2018 Q3 | 56.97 Million USD | 26.86% |
| 2017 Q2 | 58.03 Million USD | -20.04% |
| 2017 Q3 | 56.61 Million USD | -2.44% |
| 2017 Q4 | 46.46 Million USD | -17.93% |
| 2017 FY | 233.69 Million USD | -23.64% |
| 2017 Q1 | 72.57 Million USD | -2.32% |
| 2016 Q1 | 76.71 Million USD | 22.92% |
| 2016 FY | 306.03 Million USD | 22.85% |
| 2016 Q4 | 74.3 Million USD | -5.0% |
| 2016 Q3 | 78.21 Million USD | 1.84% |
| 2016 Q2 | 76.8 Million USD | 0.12% |
| 2015 Q4 | 62.4 Million USD | -20.39% |
| 2015 Q2 | 65.76 Million USD | 54.52% |
| 2015 Q1 | 42.55 Million USD | 28.76% |
| 2015 Q3 | 78.38 Million USD | 19.2% |
| 2015 FY | 249.1 Million USD | 160.06% |
| 2014 Q4 | 33.05 Million USD | 47.07% |
| 2014 FY | 95.78 Million USD | 147.23% |
| 2014 Q2 | 22.9 Million USD | 31.95% |
| 2014 Q1 | 17.35 Million USD | 48.11% |
| 2014 Q3 | 22.47 Million USD | -1.87% |
| 2013 Q4 | 11.71 Million USD | 60.78% |
| 2013 Q1 | 711.99 Thousand USD | 0.0% |
| 2013 FY | 38.74 Million USD | -4.14% |
| 2013 Q3 | 7.28 Million USD | 873.17% |
| 2013 Q2 | 748.99 Thousand USD | 5.2% |
| 2012 FY | 40.41 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbCellera Biologics Inc. | 275.23 Million USD | -9.526% |
| Alkermes plc | 996.24 Million USD | 69.741% |
| Agenus Inc. | 78.18 Million USD | -285.571% |
| Aptorum Group Limited | 10.56 Thousand USD | -2852928.582% |
| Ardelyx, Inc. | 169.93 Million USD | -77.39% |
| Dyadic International, Inc. | 9.15 Million USD | -3193.576% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -1254.653% |
| Lantern Pharma Inc. | 17.87 Million USD | -1586.197% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -4377.919% |
| Novavax, Inc. | 779.12 Million USD | 61.309% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -271.877% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -266.747% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -1452.389% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -918.209% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -467.422% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | 20.774% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -1140.202% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -696.036% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -879.659% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -255.837% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -1626.82% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -78.971% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -821.446% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -88.658% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | 83.253% |
| AlloVir, Inc. | 180.93 Million USD | -66.609% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | 32.37% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -915.602% |
| Bicycle Therapeutics plc | 216.92 Million USD | -38.967% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -75.362% |
| ChromaDex Corporation | 56.37 Million USD | -434.687% |
| Chimerix, Inc. | 93.38 Million USD | -222.791% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -2067.209% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -100.252% |
| CRISPR Therapeutics AG | 463.49 Million USD | 34.961% |
| Precision BioSciences, Inc. | 92.46 Million USD | -226.023% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -18.661% |
| Fortress Biotech, Inc. | 200.19 Million USD | -50.579% |
| Fortress Biotech, Inc. | 200.19 Million USD | -50.579% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -820.574% |
| ImmuCell Corporation | 9.61 Million USD | -3034.446% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -91.017% |
| Immix Biopharma, Inc. | 16.14 Million USD | -1767.597% |
| Incyte Corporation | 1.19 Billion USD | 74.679% |
| Innoviva, Inc. | 132.15 Million USD | -128.106% |
| IO Biotech, Inc. | 91.44 Million USD | -229.66% |
| Jaguar Health, Inc. | 42.01 Million USD | -617.484% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -78.081% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -257.496% |
| ContextLogic Inc. | 387 Million USD | 22.106% |
| MiMedx Group, Inc. | 229.72 Million USD | -31.221% |
| MEI Pharma, Inc. | 34.78 Million USD | -766.612% |
| NextCure, Inc. | 67.63 Million USD | -345.689% |
| Onconetix, Inc. | 34.9 Million USD | -763.573% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -2265.064% |
| Opthea Limited | 191.96 Million USD | -57.032% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -10855.54% |
| Vaxcyte, Inc. | 468.04 Million USD | 35.593% |
| PDS Biotechnology Corporation | 43.04 Million USD | -600.312% |
| Precigen, Inc. | 84.18 Million USD | -258.099% |
| Pharming Group N.V. | 225.49 Million USD | -33.686% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -79.62% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -315.416% |
| PureTech Health plc | 144.59 Million USD | -108.477% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -131.417% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -22.962% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -1140.202% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -31.822% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -876.866% |
| Acelyrin, Inc. | 422.06 Million USD | 28.577% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -2337816.861% |
| Summit Therapeutics Inc. | 87.68 Million USD | -243.785% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -713.326% |
| Senti Biosciences, Inc. | 94.7 Million USD | -218.305% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -143.985% |
| Elevation Oncology, Inc. | 45.44 Million USD | -563.331% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -922.943% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -7547.066% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -128.07% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -784.41% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -3467.045% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -66.271% |
| Seer, Inc. | 110.49 Million USD | -172.831% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -327.021% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -222.483% |
| ESSA Pharma Inc. | 32.13 Million USD | -838.103% |
| GlycoMimetics, Inc. | 39.28 Million USD | -667.338% |
| GT Biopharma, Inc. | 13.57 Million USD | -2120.47% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -37.129% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -49.89% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -16.2% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -431.107% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -457.417% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -2933.425% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | 25.303% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -1492.535% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -494.66% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -16.095% |
| Aptose Biosciences Inc. | 52.35 Million USD | -475.772% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -1991.903% |
| Soligenix, Inc. | 7.79 Million USD | -3767.111% |
| Century Therapeutics, Inc. | 56.07 Million USD | -437.624% |
| Kura Oncology, Inc. | 165.8 Million USD | -81.812% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -163.26% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -3523.645% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -12047.254% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -179.904% |
| Autolus Therapeutics plc | 196.72 Million USD | -53.234% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -256.085% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -158.861% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -1455.234% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | 6.311% |
| GRI Bio, Inc. | 11.33 Million USD | -2560.644% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -4172.446% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -129.777% |
| IGM Biosciences, Inc. | 265.59 Million USD | -13.502% |
| INmune Bio, Inc. | 29.89 Million USD | -908.332% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -74.7% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -647.752% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -1786.502% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -1815.002% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -385.444% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -180.362% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -9.343% |
| Verastem, Inc. | 92.08 Million USD | -227.365% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -1580.422% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -62.31% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -148.298% |
| Histogen Inc. | 14.27 Million USD | -2012.185% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -1778.417% |
| Surrozen, Inc. | 18.55 Million USD | -1525.073% |
| Organovo Holdings, Inc. | 14.91 Million USD | -1921.126% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -5822.142% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -405.17% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -1075.385% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -541.303% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -3849.393% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -69.225% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -522.216% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -23.039% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -1861.732% |
| Apollomics, Inc. | 54.14 Million USD | -456.799% |
| Amarin Corporation plc | 272.35 Million USD | -10.682% |
| Mesoblast Limited | 5.9 Million USD | -5007.608% |
| Turnstone Biologics Corp. | 78.33 Million USD | -284.808% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -23.484% |
| Synaptogenix, Inc. | 8.31 Million USD | -3525.888% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -1966.715% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -19.124% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -804.441% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -3313.464% |
| Exelixis, Inc. | 1.58 Billion USD | 81.002% |
| Better Therapeutics, Inc. | 38.26 Million USD | -687.86% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -29.908% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | 64.751% |
| NLS Pharmaceutics AG | 11.8 Million USD | -2453.141% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -3648.502% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -905.071% |
| Gritstone bio, Inc. | 148.37 Million USD | -103.17% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -337.767% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -1742.585% |
| Avid Bioservices, Inc. | 25.99 Million USD | -1059.605% |
| Insmed Incorporated | 949.26 Million USD | 68.244% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -1821.32% |
| MediWound Ltd. | 18.86 Million USD | -1497.684% |
| OmniAb, Inc. | 83.89 Million USD | -259.319% |
| Alector, Inc. | 248.8 Million USD | -21.161% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -28.656% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -476.929% |
| Zai Lab Limited | 547.47 Million USD | 44.938% |
| Revance Therapeutics, Inc. | 398.65 Million USD | 24.383% |
| Aura Biosciences, Inc. | 84.99 Million USD | -254.686% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -21.977% |
| Immunic, Inc. | 99.22 Million USD | -203.812% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -89.578% |
| Veracyte, Inc. | 357.93 Million USD | 15.78% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 96.656% |
| FibroGen, Inc. | 398.11 Million USD | 24.28% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -2021.4% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -4276.5% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -4130.457% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 90.741% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -1065.118% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | 4.768% |
| TG Therapeutics, Inc. | 198.47 Million USD | -51.884% |
| Galecto, Inc. | 35.62 Million USD | -746.131% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -640.866% |
| Fortrea Holdings Inc. | 457.3 Million USD | 34.08% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -455.383% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -943.878% |
| XBiotech Inc. | 37.51 Million USD | -703.655% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -337.767% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -1359.882% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -112.198% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -204.265% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -172.274% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | 68.541% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -945.072% |
| Vaxxinity, Inc. | 56.05 Million USD | -437.816% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | 29.999% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -1251.294% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -171.903% |
| NexImmune, Inc. | 28.16 Million USD | -970.208% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -5350.259% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -1584.789% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 89.292% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -1084.065% |
| Scopus BioPharma Inc. | 11.71 Million USD | -2473.232% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -137.247% |
| Ainos, Inc. | 12.95 Million USD | -2227.328% |
| Pluri Inc. | 22.48 Million USD | -1240.974% |
| Prothena Corporation plc | 282.4 Million USD | -6.744% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -50.709% |
| Celularity Inc. | 215.05 Million USD | -40.172% |
| Rallybio Corporation | 78.93 Million USD | -281.912% |
| Cue Biopharma, Inc. | 19.54 Million USD | -1442.58% |
| MeiraGTx Holdings plc | 151.07 Million USD | -99.533% |
| Omeros Corporation | 94.75 Million USD | -218.151% |
| Humacyte, Inc. | 23.49 Million USD | -1182.934% |
| Immunocore Holdings plc | 308.04 Million USD | 2.139% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -8792.36% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -247.034% |
| Blueprint Medicines Corporation | 722.86 Million USD | 58.298% |
| CalciMedica, Inc. | 21.81 Million USD | -1281.725% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -303.765% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -87.773% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -75.984% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -2.208% |
| Pulmatrix, Inc. | 22.03 Million USD | -1267.869% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -771.876% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -239.22% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | 45.346% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -315.502% |
| Cytokinetics, Incorporated | 173.61 Million USD | -73.635% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -775.827% |
| Nutriband Inc. | 5.73 Million USD | -5157.227% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -591.195% |
| Vor Biopharma Inc. | 126.03 Million USD | -139.178% |
| Roivant Sciences Ltd. | 1.18 Billion USD | 74.65% |
| Evogene Ltd. | 27.79 Million USD | -984.746% |
| ProKidney Corp. | 151.52 Million USD | -98.949% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -306.405% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -3818.896% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | 50.922% |
| CorMedix Inc. | 48.95 Million USD | -515.737% |
| BioLineRx Ltd. | 50.8 Million USD | -493.384% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -100.034% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -691.792% |
| Atai Life Sciences N.V. | 125.78 Million USD | -139.656% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -269.247% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -270.292% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -19.362% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -820.742% |
| MediciNova, Inc. | 10.9 Million USD | -2665.538% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -134.009% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -4052.49% |
| GeoVax Labs, Inc. | 6.02 Million USD | -4905.685% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | 36.718% |
| Biomea Fusion, Inc. | 126.13 Million USD | -138.991% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | 77.021% |
| Mereo BioPharma Group plc | 35.84 Million USD | -741.055% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -57.754% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -31.092% |
| Absci Corporation | 73.66 Million USD | -309.213% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -992.927% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -125.654% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -24.483% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -15.037% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -44.933% |
| Allakos Inc. | 196.05 Million USD | -53.758% |
| Imunon, Inc. | 20.31 Million USD | -1384.218% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -165.668% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | 18.22% |
| BioAtla, Inc. | 129.68 Million USD | -132.445% |
| NLS Pharmaceutics AG | 11.8 Million USD | -2453.141% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -1802.739% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -254.991% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -621.9% |
| XOMA Corporation | 46.46 Million USD | -548.798% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -171.16% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -111.6% |
| aTyr Pharma, Inc. | 12.97 Million USD | -2222.606% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -190.819% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -74.38% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -18.326% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -705.846% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -3565.141% |
| Akari Therapeutics, Plc | 16.8 Million USD | -1693.711% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -13156.595% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -0.713% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -4380.058% |
| UroGen Pharma Ltd. | 138.88 Million USD | -117.046% |
| Sutro Biopharma, Inc. | 243 Million USD | -24.049% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -4043.872% |
| Orgenesis Inc. | 45.75 Million USD | -558.808% |
| Entera Bio Ltd. | 8.86 Million USD | -3302.381% |
| GH Research PLC | 41.22 Million USD | -631.287% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -1072.596% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -262.962% |
| Xencor, Inc. | 306.97 Million USD | 1.8% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -6010.156% |
| Replimune Group, Inc. | 234.77 Million USD | -28.401% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -1371.218% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -57.173% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -4380.058% |
| Portage Biotech Inc. | 18.19 Million USD | -1556.415% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -4052.49% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -187.203% |
| OncoCyte Corporation | 25.63 Million USD | -1075.844% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -4845.381% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -2531.137% |
| Purple Biotech Ltd. | -22.46 Million USD | 1441.75% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -1729.193% |
| scPharmaceuticals Inc. | 65.17 Million USD | -362.504% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -3466.313% |
| HilleVax, Inc. | 133.34 Million USD | -126.068% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -2830.977% |
| Tharimmune, Inc. | 9.45 Million USD | -3088.197% |
| Genprex, Inc. | 31.06 Million USD | -870.526% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -60.752% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -860.739% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -39305.359% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -5434.34% |
| OKYO Pharma Limited | 8243.57 USD | -3656701.604% |
| Savara Inc. | 15.74 Million USD | -1814.582% |
| Curis, Inc. | 58.35 Million USD | -416.581% |
| Daré Bioscience, Inc. | 33.6 Million USD | -796.925% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -5819.523% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -3940.357% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -1015.576% |
| BeiGene, Ltd. | 3.28 Billion USD | 90.828% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -1411.843% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | 39.561% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -96.191% |
| Erasca, Inc. | 141.52 Million USD | -113.002% |
| bluebird bio, Inc. | 240.23 Million USD | -25.483% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -6558.996% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | 82.737% |
| DBV Technologies S.A. | 92.16 Million USD | -227.095% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -6558.996% |
| Moderna, Inc. | 6.39 Billion USD | 95.285% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -607.482% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -1998.364% |
| Molecular Templates, Inc. | 63.09 Million USD | -377.803% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -351.944% |
| Travere Therapeutics, Inc. | 472 Million USD | 36.134% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -110.347% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -385.569% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -594.364% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -44.838% |
| MacroGenics, Inc. | 217.21 Million USD | -38.78% |
| RenovoRx, Inc. | 11.39 Million USD | -2545.235% |
| Adicet Bio, Inc. | 152.03 Million USD | -98.273% |
| Prime Medicine, Inc. | 186.63 Million USD | -61.516% |
| Aditxt, Inc. | 25.95 Million USD | -1061.627% |
| Adagene Inc. | 41.83 Million USD | -620.634% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -4023.761% |
| Quantum-Si incorporated | 111.65 Million USD | -169.975% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -75.415% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -1967.882% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -741.525% |
| SciSparc Ltd. | 9.01 Million USD | -3245.367% |
| Vericel Corporation | 142.04 Million USD | -112.23% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -3382.3% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -1205.627% |
| Generation Bio Co. | 144.46 Million USD | -108.664% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -263.063% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -248.659% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -1.938% |
| Invivyd, Inc. | 205.75 Million USD | -46.51% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -317.759% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -3114.276% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -300.578% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -2830.407% |
| 2seventy bio, Inc. | 289.88 Million USD | -3.989% |
| ADMA Biologics, Inc. | 66.58 Million USD | -352.724% |
| Clene Inc. | 41.07 Million USD | -633.94% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -2253.636% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -450.133% |
| GeoVax Labs, Inc. | 6.02 Million USD | -4905.685% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | 14.372% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -720.676% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -793.771% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -190.69% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -825.008% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -77.035% |
| Vir Biotechnology, Inc. | 767.72 Million USD | 60.734% |
| Evaxion Biotech A/S | 22.27 Million USD | -1253.619% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -122.401% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -28.341% |
| Trevena, Inc. | 38.41 Million USD | -684.763% |
| Surrozen, Inc. | 18.55 Million USD | -1525.073% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -277.073% |
| Cingulate Inc. | 22.75 Million USD | -1224.524% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 4123.639% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -574.885% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -3561.078% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -193.932% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | 60.024% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -385.632% |
| Clearmind Medicine Inc. | 8.74 Million USD | -3348.563% |
| Kronos Bio, Inc. | 128.11 Million USD | -135.292% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -258.563% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -10177.959% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -198.978% |
| Statera Biopharma, Inc. | 28.82 Million USD | -945.634% |
| ImmunityBio, Inc. | 362.87 Million USD | 16.926% |
| Korro Bio, Inc. | 84.53 Million USD | -256.603% |
| Kineta, Inc. | 21.15 Million USD | -1324.896% |
| BioVie Inc. | 31.95 Million USD | -843.502% |
| Codexis, Inc. | 66.51 Million USD | -353.187% |
| Celularity Inc. | 215.05 Million USD | -40.172% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -33.02% |
| Celcuity Inc. | 66.23 Million USD | -355.156% |
| Virax Biolabs Group Limited | 6.54 Million USD | -4504.37% |
| Cibus, Inc. | 320.3 Million USD | 5.886% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -601.049% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -790.707% |
| IN8bio, Inc. | 30.33 Million USD | -893.674% |
| Kodiak Sciences Inc. | 277.32 Million USD | -8.701% |
| Annexon, Inc. | 143.72 Million USD | -109.744% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -136.264% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -1215.863% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -47001.719% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | 61.332% |
| Eyenovia, Inc. | 25.4 Million USD | -1086.514% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -114.839% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -5319.831% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -280.942% |
| Arcellx, Inc. | 200.19 Million USD | -50.576% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -556.756% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -39.296% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -2927.528% |
| Moolec Science SA | 52.75 Million USD | -471.465% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -393.067% |
| Geron Corporation | 70.44 Million USD | -327.948% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -547.725% |
| Royalty Pharma plc | 862.4 Million USD | 65.045% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -220.447% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -3131.725% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -1232.172% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -45.059% |
| Humacyte, Inc. | 23.49 Million USD | -1182.934% |
| Structure Therapeutics Inc. | 102.77 Million USD | -193.312% |
| 89bio, Inc. | 151.2 Million USD | -99.367% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -276.193% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -1973.253% |
| Genelux Corporation | 24.33 Million USD | -1138.755% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -788.633% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -74.381% |
| Notable Labs, Ltd. | 14.77 Million USD | -1940.968% |
| Liquidia Corporation | 87.98 Million USD | -242.62% |
| Mustang Bio, Inc. | 48.5 Million USD | -521.536% |
| Immunovant, Inc. | 282.7 Million USD | -6.629% |
| Quantum-Si incorporated | 111.65 Million USD | -169.975% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -1237.167% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -1317.459% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -195.505% |
| Acasti Pharma Inc. | 11.3 Million USD | -2567.472% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -1215.168% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -1786.502% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -547.697% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -26469.391% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -1797.589% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -933.889% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -628.424% |
| PepGen Inc. | 84.76 Million USD | -255.627% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -917.35% |
| United Therapeutics Corporation | 885.1 Million USD | 65.942% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -1216.552% |
| Solid Biosciences Inc. | 104.31 Million USD | -188.981% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -821.149% |
| Immuneering Corporation | 58.41 Million USD | -416.069% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -5822.142% |
| Silo Pharma, Inc. | 3.92 Million USD | -7586.437% |
| Belite Bio, Inc | 31.66 Million USD | -851.91% |
| XOMA Corporation | 46.46 Million USD | -548.798% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -346.264% |
| Bionomics Limited | 17.89 Billion USD | 98.315% |
| Apogee Therapeutics, Inc. | 93 Million USD | -224.13% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 944.874% |
| uniQure N.V. | 285.08 Million USD | -5.74% |
| Cassava Sciences, Inc. | 105.95 Million USD | -184.503% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -4023.761% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -55.221% |
| Forte Biosciences, Inc. | 32.47 Million USD | -828.198% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -3528.113% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -925.518% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -5319.831% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -2021.4% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -3291.281% |
| Altimmune, Inc. | 30.55 Million USD | -886.553% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | 29.51% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 944.874% |
| Compugen Ltd. | 43.97 Million USD | -585.568% |
| Peak Bio, Inc. | 1249.13 USD | -24132776.482% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -306.707% |
| Benitec Biopharma Inc. | 22.38 Million USD | -1246.846% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -23.957% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -956.129% |
| Zura Bio Limited | 62.63 Million USD | -381.259% |
| PolyPid Ltd. | 21.04 Million USD | -1332.411% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -1752.12% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -956.129% |
| Instil Bio, Inc. | 85.78 Million USD | -251.403% |
| argenx SE | 1.53 Billion USD | 80.343% |
| Immunome, Inc. | 122.82 Million USD | -145.441% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -521.895% |
| Verona Pharma plc | 67.15 Million USD | -348.913% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -1064.578% |
| Shattuck Labs, Inc. | 93.61 Million USD | -222.015% |
| CervoMed Inc. | 14.95 Million USD | -1915.348% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -326.362% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -3428.219% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -491.08% |
| Moolec Science SA | 52.75 Million USD | -471.465% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -1732.703% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -127.416% |
| AnaptysBio, Inc. | 181.56 Million USD | -66.027% |
| Design Therapeutics, Inc. | 78.19 Million USD | -285.537% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -246.332% |
| NeurAxis, Inc. | 8.82 Million USD | -3317.347% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -2295.32% |
| Lumos Pharma, Inc. | 38.66 Million USD | -679.648% |
| Achilles Therapeutics plc | 75.25 Million USD | -300.573% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -1064.578% |
| 180 Life Sciences Corp. | 13.47 Million USD | -2136.698% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -1037.446% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -10177.959% |
| Nutriband Inc. | 5.73 Million USD | -5157.227% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -172.117% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -441.662% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -492.486% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -356.06% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -456.973% |
| Palisade Bio, Inc. | 13.32 Million USD | -2163.146% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -563.857% |
| Beam Therapeutics Inc. | 554.19 Million USD | 45.606% |
| Neurogene Inc. | 55.58 Million USD | -442.344% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -21.314% |
| AEON Biopharma, Inc. | 48.42 Million USD | -522.46% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -211.706% |
| Sesen Bio, Inc. | 78.38 Million USD | -284.597% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -260.894% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -2294.959% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | 33.158% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -242.987% |
| Athira Pharma, Inc. | 125.46 Million USD | -140.265% |
| Vaccinex, Inc. | 23.45 Million USD | -1185.231% |
| HCW Biologics Inc. | 21.02 Million USD | -1333.602% |
| XOMA Corporation | 46.46 Million USD | -548.798% |
| Nektar Therapeutics | 190.9 Million USD | -57.908% |
| Arvinas, Inc. | 480 Million USD | 37.198% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -13156.595% |
| Merus N.V. | 200.49 Million USD | -50.354% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -191.666% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -770.742% |
| Rezolute, Inc. | 70.38 Million USD | -328.277% |
| Clene Inc. | 41.07 Million USD | -633.94% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -1740.532% |
| BeyondSpring Inc. | 24.86 Million USD | -1112.351% |
| Synlogic, Inc. | 58.53 Million USD | -415.019% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -1584.837% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -6610.841% |
| Peak Bio, Inc. | 1249.13 USD | -24132776.482% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -398.711% |
| Krystal Biotech, Inc. | 160.42 Million USD | -87.907% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -11.388% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | 13.386% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -13877.199% |
| MannKind Corporation | 125.59 Million USD | -140.014% |
| Ikena Oncology, Inc. | 84.57 Million USD | -256.422% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -3024.816% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -236.437% |
| Gossamer Bio, Inc. | 183.75 Million USD | -64.047% |
| CohBar, Inc. | 12.38 Million USD | -2333.353% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -494.297% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -992.927% |
| Legend Biotech Corporation | 583.14 Million USD | 48.306% |
| Mural Oncology plc | 192.07 Million USD | -56.948% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -348.942% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -1767.116% |
| Disc Medicine, Inc. | 91.12 Million USD | -230.81% |
| Champions Oncology, Inc. | 28.11 Million USD | -972.398% |
| REGENXBIO Inc. | 321.15 Million USD | 6.136% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -5522.791% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -440.661% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -673.732% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -163.605% |
| Vaxart, Inc. | 90.72 Million USD | -232.265% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -3438.154% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -604.422% |
| Cellectis S.A. | 97.32 Million USD | -209.752% |
| Longeveron Inc. | 21.25 Million USD | -1318.593% |
| Repare Therapeutics Inc. | 167.35 Million USD | -80.125% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | 77.848% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -298.508% |
| Revolution Medicines, Inc. | 498.76 Million USD | 39.561% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -4431.735% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -585.833% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -304.144% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -332.902% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -2625.597% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 93.687% |
| Denali Therapeutics Inc. | 527.23 Million USD | 42.824% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -3382.3% |
| Veru Inc. | 101.34 Million USD | -197.441% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -1187.867% |
| Cingulate Inc. | 22.75 Million USD | -1224.524% |
| Passage Bio, Inc. | 108.38 Million USD | -178.12% |
| Context Therapeutics Inc. | 25.07 Million USD | -1102.312% |
| Exicure, Inc. | 14.07 Million USD | -2041.596% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -46.29% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -596.176% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -3184.75% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -19.395% |
| Nuvalent, Inc. | 149.49 Million USD | -101.65% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -3636.887% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -190.836% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -1305.431% |
| OmniAb, Inc. | 83.89 Million USD | -259.319% |
| Anew Medical, Inc. | 1.3 Million USD | -23073.547% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -820.068% |
| Lipocine Inc. | 15.08 Million USD | -1898.994% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -339.991% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -295.854% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -647.752% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -162.49% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -1246.725% |
| Sage Therapeutics, Inc. | 664.14 Million USD | 54.611% |
| Ocugen, Inc. | 71.56 Million USD | -321.215% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -221.15% |
| Q32 Bio Inc. | 92.68 Million USD | -225.26% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -1323.685% |
| Alumis Inc. Common Stock | 158.17 Million USD | -90.582% |
| Equillium, Inc. | 50.6 Million USD | -495.682% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -383.048% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -2067.846% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -1497.929% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -542.054% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -177.922% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -2332.483% |
| Dominari Holdings Inc. | 23.83 Million USD | -1164.741% |
| Edesa Biotech, Inc. | 9.22 Million USD | -3168.556% |
| vTv Therapeutics Inc. | 11.9 Million USD | -2431.712% |
| Bio-Techne Corporation | 563.03 Million USD | 46.46% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | 26.261% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -12.165% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -127.894% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -1991.812% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -84.153% |
| Nkarta, Inc. | 131.65 Million USD | -128.979% |
| BioCardia, Inc. | 12.12 Million USD | -2387.014% |
| Iterum Therapeutics plc | 47.46 Million USD | -535.062% |